TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) Investor Securities Class Action Lawsuit 08/22/2022

  • If you purchased a significant amount of shares of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) between December 29, 2020 and August 3, 2022, and / or if you purchased any NYSE American: AMPE shares prior to December 2020 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 17, 2022. NYSE American: AMPE investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

August 22, 2022 - An investor in shares of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) filed a lawsuit in the U.S. District Court for the District of Colorado over alleged violations of Federal Securities Laws by Ampio Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between December 29, 2020 and August 3, 2022. Englewood, CO based ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)